In addition, this assay also detected variants in other relevant genes associated with cancer pathways and/or with clinical implications for CRC patients, such as PIK3CA, BRAF, EGFR, APC, and TP53, among others [28,32,33]. This evidence concerns the gene APC and colorectal carcinoma.